[1]
K. Saleem, A. Ali, S. Rafique, N. Rani, and B. Wahid, “Successful retreatment of HCV relapse patient with 4 weeks long sofsobuvir, ribavirin, and daclatasvir combination: Case Series”, BioSci Rev., vol. 2, no. 3, pp. 17-25, Sep. 2020.